May 13, 2009
By:
George Koroneos, Online Content & News Editor
Two Democratic Congressman have brewed up new legislation to target pharma erectile dysfunction ads rather than going after advertisements with sexually suggestive material in general. Industry experts don't think they have a chance, but the bill could still be a pain for fans of Viva Viagra.
|
May 7, 2009
By:
George Koroneos, Online Content & News Editor
As it readies submission for a once-weekly diabetes injectable, Amylin announces that it will trim 35 percent of its sales force and put focus on specialty physicians.
|
May 7, 2009
By:
George Koroneos, Online Content & News Editor
New prescriptions for antiviral treatments get huge boost due to H1N1 epidemic. Numbers exceed those seen during this year's influenza season, and the numbers are climbing.
|
Apr 29, 2009
By:
George Koroneos, Online Content & News Editor
Ortho-McNeil is reaching out to the adult ADHD segment through the popular social networking site. The plan is to grow followers through education and unbranded information. Pharm Exec takes a look at the new site.
|
Apr 29, 2009
By:
George Koroneos, Online Content & News Editor
As the US government weighs its options on whether to commission a vaccine for the new H1N1 strain of influenza, pharma companies gear up for a possible epidemic.
|
Apr 22, 2009
By:
George Koroneos, Online Content & News Editor
The two pharma giants announced plans to form a new specialty company focused on HIV drug development. The new, independent firm will have a total of 11 drugs on the market, with another six on the horizon, securing its place as a powerhouse in the HIV market.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
